Greffex is a company specializing in the genetic engineering. It develops GREVAX, a genetic platform for the production of vaccines. The company focuses on medicines against infectious diseases, including pandemic influenza strains, Anthrax and Dengue fever, malaria, hepatitis C, respiratory syncytial virus (RSV), Ebola, HPV, plague, tuberculosis, etc.